Enter assignee name

EPO Patents = 6

Forward Citations = 9

Loading Chart...

31 inventors (with patents filed for the assignee):

Dragan Grabulovski (7 out of 13 patents)

Julian Bertschinger (7 out of 8 patents)

Patricia Henne (3 out of 4 patents)

4. Richard Woods (3 out of 5 patents)

5. Ulrike Von Der Bey (3 out of 3 patents)

6. Simon Brack (3 out of 3 patents)

7. Sarah Batey (3 out of 3 patents)

8. Michela Silacci Melkko (2 out of 3 patents)

9. Fabian Buller (2 out of 2 patents)

10. Ulrich Wüllner (2 out of 2 patents)

11. Irene Zbinden (2 out of 2 patents)

12. Isabella Attinger-Toller (2 out of 3 patents)

13. Susann König-Friedrich (2 out of 2 patents)

14. Frédéric Mourlane (2 out of 2 patents)

15. Barbara Zubler (1 out of 2 patents)

7 patents: Sort by Forward Citations

1. 10722589 - FGFR3 binding molecules (2020-07-28),

2. 10364419 - Human serum albumin binding compounds and fusion proteins thereof (2019-07-30),

3. 9790475 - Human serum albumin binding compounds and fusion proteins thereof (2017-10-17),

4. 9593314 - Binding molecules with antitumoral activity (2017-03-14),

5. 9376477 - IL-17 binding compounds and medical uses thereof (2016-06-28),

6. 9315557 - IL-17A binding molecules and medical uses thereof (2016-04-19),

7. 9085760 - Chymase binding compounds and medical uses thereof (2015-07-21),

Covagen AG is a biotechnology company focused on the discovery and development of novel bispecific protein therapeutics for the treatment of cancer and immune-related diseases. The company's proprietary platform allows for the rapid and efficient generation of bispecific antibodies with improved therapeutic properties. Covagen's innovative approach has the potential to revolutionize the treatment of various diseases by targeting multiple pathways simultaneously.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#68 in Zug

#1,301 in Switzerland

Zug, Switzerland

Covagen Ag